K Number
K083182
Device Name
DATACOM DC PACS
Date Cleared
2009-03-04

(127 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The DATACOM™ DC-PACS is intended for the manipulation, management, and display of medical images. It can manage and display images from different modalities and interfaces and can distribute those images to various workstation, image storage and printing devices using DICOM or similar standards.
Device Description
The DATACOM™ PACS system is based on DICOM standard application. The main function of DC-PACS is about medical image management within a PACS environment. It's including Image archival, retrieval and distribution of medical images.
More Information

Not Found

No
The summary describes a standard PACS system focused on image management and display using DICOM, with no mention of AI, ML, or related concepts like image analysis or interpretation beyond basic processing.

No.
The device is intended for the manipulation, management, and display of medical images, which is not considered a therapeutic use.

No
The device is described as a system for manipulation, management, and display of medical images, focusing on image archival, retrieval, and distribution. It does not mention analysis or interpretation of images for the purpose of diagnosis.

Unknown

The summary describes a PACS system which is primarily software for managing and displaying medical images. However, it doesn't explicitly state that the device is only software and doesn't include any associated hardware components (like a dedicated server or workstation).

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the "manipulation, management, and display of medical images." This is related to medical imaging and data handling, not the examination of specimens derived from the human body for the purpose of providing information for diagnosis, monitoring, or treatment.
  • Device Description: The description focuses on "medical image management within a PACS environment," including archival, retrieval, and distribution. Again, this is about image handling, not in vitro testing.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any other components typically associated with in vitro diagnostics.

IVD devices are specifically designed to perform tests on samples taken from the body to provide diagnostic information. This device is designed to manage and display images generated by other medical devices (like MRI, CT, X-ray, etc.).

N/A

Intended Use / Indications for Use

The DATACOM™ DC-PACS is intended for the manipulation, management, and display of medical images. It can manage and display images from different modalities and interfaces and can distribute those images to various workstation, image storage and printing devices using DICOM or similar standards. Typical users of this system are trained medical professionals, including physicians, nurses, technicians and computer system professionals.

Product codes (comma separated list FDA assigned to the subject device)

LLZ

Device Description

The DATACOM™ PACS system is based on DICOM standard application. The main function of DC-PACS is about medical image management within a PACS environment. It's including Image archival, retrieval and distribution of medical images.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

trained medical professionals, including physicians, nurses, technicians and computer system professionals.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The submission contains the results of software validation that the risks analysis and the potential hazards have been classified Minor.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K022710

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

งค์ที่ย์ที่ตัวตัวตาม เกม FDA CDRH DMC ADMINISTRATIVE INFORMATION OCT 28 2008 2.1 510(k) Summary of Safety and Effectiveness (Per 21 CFR 807.92) Received General Information Establishment 트 Manufacturer: DATACOM Technology Corp. Address: 6F, No.69-3, Sec.2, Chung Cheng E. Rd., Tam Shui, Taipei, 25170, Taiwan, ROC 지 . Owner Number: 10026153 Contact Person: Dr. Jen, Ke-Min E-mail: ceirs.jen@msa.hint.net (official correspondent) 886-3-5208829 (Tel); 886-3-5209783 (Fax) No.58, Fu Chiun Street, Hsin Chu City, 30067, Taiwan, ROC Address: . Date Prepared: October 24, 2008 Device Information DATACOM™ DC-PACS Proprietary Name: SYSTEM, IMAGE PROCESSING, RADIOLOGICAL tion Name: Class II ● Regulation Number: 892.2050 Product Code: . LLZ Safety and Effectiveness Information Predicate Device:

Claim of Substantial Equivalence (SE) is made to Taiwan Electronics Data Processing Corporation Smart PACS (K022710)

  • Device Description:
    The DATACOM™ PACS system is based on DICOM standard application. The main function of DC-PACS is about medical image management within a PACS environment. It's including Image archival, retrieval and distribution of medical images.

MAR. 4 2009

K083182

Proprietary Name:DATA
Classification Name:SYSTEM

1

E-MAIL:Kennethlogstacom con

0 Intended Use:

The DATACOM™ DC-PACS is intended for the manipulation, management, and display of medical images. It can manage and display images from different modalities and interfaces and can distribute those images to various workstation, image storage and printing devices using DICOM or similar standards. Typical users of this system are trained medical professionals, including physicians, nurses, technicians and computer system professionals.

Technological Characteristics

The DATACOM™ DC-PACS is a software server application and does not contact the patient, nor does it control any life sustaining devices. A physician, providing ample opportunity for competent human intervention interprets images and information being displayed and printed.

Substantial Equivalence (SE)

A claim of substantial equivalence is made to Smart PACS (K022710). Both of them have the same working principle and technologies. The differences are due to the feature design aspects, not relating to the safety or effectiveness aspects. Besides, the submission contains the results of software validation that the risks analysis and the potential hazards have been classified Minor. Thus they are substantially equivalent.

Keiziten

Dr. Jen, Ke-Min official correspondent for DATACOM Technology Corp.

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Rockville MD 20850

Food and Drug Administration 9200 Corporate Boulevard

MAR 4 2009

DATACOM Technology Corp. % Dr. Jen, Ke-Min Official Correspondent ROC Chinese-European Industrial Research Society No. 58, Fu Chiun Street Hsin Chu City , 30067, ROC TAIWAN

Re: K083182

Trade/Device Name: DATACOM™ DC-PACS Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: January 15, 2009 Received: January 21, 2009

Dear Dr. Jen, Ke-Min:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Image /page/2/Picture/13 description: The image shows a partial view of a seal or emblem, featuring a stylized graphic element resembling waves or abstract shapes. To the left of this graphic, a portion of text is visible, reading "DEPARTMENT OF HEALTH &". The text is arranged vertically, following the curve of the emblem, suggesting it is part of a circular design. The overall impression is that of an official or organizational symbol related to health.

3

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding os substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

21 CFR 876.xxx(Gastroenterology/Renal/Urology)(240) 276-0115
21 CFR 884.xxx(Obstetrics/Gynecology)(240) 276-0115
21 CFR 892.xxx(Radiology)(240) 276-0120
Other(240) 276-0100

Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufactures, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry.suppot/index.html.

Sincerely yours,

Janine M. Morris

anine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Image /page/4/Picture/0 description: The image is a low-resolution black and white photograph. The image shows a building with a circular object on the left side of the building. The building appears to have multiple stories and a complex roof structure. Due to the low resolution, it is difficult to discern specific details about the building's architecture or the surrounding environment.

F NO.69-3,SEC.2,CHUNG CHE TAM SHUI, TAIPEI, TAIWAN TEL:886-2-28094611 E-MAIL:Kenneth@datacom.com.tw

2.2 FDA Indication for Use Form :

Indications for Use

510(k) Number: K083182

Device Name: DATACOM Technology Corp.

DATACOM™ DC-PACS

Indications for Use :

  • The DATACOM™ DC-PACS is intended for the manipulation, management, and display of medical images. It can manage and display images from different modalities and interfaces and can distribute those images to various workstation, image storage and printing devices using DICOM or similar standards.
    Typical users of this system are trained medical professionals, including physicians, nurses, technicians and computer system professionals.

Prescription Use

AND/OR

Over-The-Counter Use

(Part 21 CFR 801 Subpart D)

(21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number. K08318

Pe